Factores de riesgo para morbilidad materna extrema en gestantes
| Contribuinte(s) |
Carillo, Sara Paola Villaveces, Mariana |
|---|---|
| Data(s) |
06/06/2014
|
| Resumo |
Introducción: La morbilidad materna extrema es un término usado para definir cualquier condición obstétrica severa que amenaza la vida y requiere una intervención médica urgente con el fin de prevenir la probable muerte materna. Con el presente estudio se pretendió evaluar los factores de riesgo para morbilidad materna extrema en las gestantes del Hospital Universitario Mayor. Metodología Se realizó un estudio de casos y controles, comparando pacientes con MME y sin MME en una relación de 1:1. Se realizó un muestreo aleatorio simple teniendo en cuenta 95% de la población apareadas por diagnóstico de ingreso. Resultados Se incluyeron un total de 110 pacientes (55 en cada grupo). Ambas poblaciones fueron comprables. Ser de estrato socioeconómico bajo (p 0,000), haber tenido 2 o menos partos (p 0,000), ser tipo de sangre negativo (p0.000) realizar entre 0-3 controles prenatales (p 0,000), tener antecedente de preeclampsia (p 0,000), hipotiroidismo (p 0,000), o trastorno bipolar (p 0,000), son factores de riesgo significativos para presentar MME. Entre los factores protectores están tener más de tres partos OR 0,60 (IC95%: 0,17-0,82, p=0,00) y 7 o más controles prenatales OR 0,23 (IC95%: 0,09-0,55, p=0,000). Resultados concordantes con la literatura Discusión: Es importante dar a conocer los resultados del presente estudio para promover las campañas de prevención primaria, secundaria y terciaria con el fin de evitar las altas complicaciones que se pueden presentar en las mujeres en edad fértil de nuestra población. Introduction: The extreme maternal morbidity is a term used to define any severe obstetric life -threatening condition that requires urgent medical intervention in order to prevent the probable maternal death. The present study was intended to assess risk factors for extreme maternal morbidity in Hospital Univesritario Mayor. Methodology A case-control study was performed comparing patients with and without MME in a ratio of 1:1. Simple random sampling was conducted.taking into account the 95 % of the population Results A total of 110 patients (55 in each group) were included. Both populations were comparable. Bearing to a low socioeconomic status (p 0.000), having had 2 -or fewer- births (p 0.000), being negative blood type (p0.000), performing only 0-3 prenatal controls ( p 0.000), having a history of preeclampsia (p 0.000 ), hypothyroidism (p 0.000 ) or bipolar disorder ( p 0.000 ) are significant risk factors to present MME . Discussion: It is important to comunicate the results of this study to promote the correct information to the campaigns, promoting primary, secondary and tertiary prevention for the purpose of avoiding high complications that can occur in women of childbearing age |
| Formato |
application/pdf |
| Identificador | |
| Idioma(s) |
spa |
| Publicador |
Facultad de Medicina |
| Direitos |
info:eu-repo/semantics/openAccess |
| Fonte |
instname:Universidad del Rosario reponame:Repositorio Institucional EdocUR 1. WHO, UNICEF, UNFPA, The WB. Trends in Maternal Mortality: 1990–2008. Geneva: WHO, 2010. 2. Patton GC, Coffey C, Sawyer SM, Viner RM, Haller DM, Bose K, et al . Global patterns of mortality in young people: a systematic analysis of population health data. Lancet, 2009. 374:881–892. 3. Mortalidad Materna en América Latina Disponible en URL: http://www.clam.org.br/publique/cgi/cgilua.exe/sys/start.htm?infoid=8676&sid=21 4. Análisis de Situación de Salud según regiones en Colombia. Ministerio De Salud Y Protección Social. Dirección de Epidemiología y demografía grupo ASIS. 2013 5. Observatorio de Mortalidad Materna en México. Disponible en URL: http://www.omm.org.mx/index.php/defs.html 6. Tuncalp O¨, Hindin MJ, Souza JP, Chou D, Say L. The prevalence of maternal near miss: a systematic review. BJOG 2012;119:653–661. 7. Van den Akker T, Beltman J, Leyten J, Mwagomba B, Meguid T, et al. The WHO Maternal Near Miss Approach: Consequences at Malawian District Level. PLoS ONE 8(2013) 8. Say L. Rain R. A systematic review of inequalities in the use of maternal health care in developing countries: examining the scale of the problem and the importance of context. Bulletin of the World Health Organization 2007. 85, (10), 733-820 9. Conde-Agudelo A, Belizan JM, Lammers C. Maternal-perinatal morbidity and mortality associated with adolescent pregnancy in Latin America: Cross-sectional study. American Journal of Obstetrics and Gynecology 2004. 192:342–349 10. Estrategia y Plan de Acción Regionales sobre la Salud del Recién Nacido en el Contexto del Proceso Continuo de la Atención de la Madre, del Recién Nacido y del Niño. OPS-UNICEF , 2008. 11. Estrategia de UNICEF en América Latina y el Caribe para contribuir a la reducción de la morbi-mortalidad materna, neonatal e infantil. UNICEF, 2011-2015 12. DANE, Sistema de Información en Salud del Ministerio de la Protección Social, SISPRO, Cubo de indicadores-2005 a 2010. 13. Maine D. Detours and shortcuts on the road to maternal mortality reduction. Lancet 2007;370:1380–2 14. Secretary-General UN. Global Strategy for Women’s and Children’s Health. New York: United Nations, 2010. 15. Al-Azawi F, Kelly M. An investigation of maternal morbidity with the identification of lifethreatening “near miss” episodes. Health Trends, 1991; 23: 13-15. 16. Campbell L, Klocke R, Implications for the Pregnant Patient. Amer Jour Resp and Crit Care Medicine 2001;163:5, 1051-1054 17. Souza JP, Cecatti JG, Haddad SM, Parpinelli MA, Costa ML, et al. The WHO Maternal Near-Miss Approach and the Maternal Severity Index Model (MSI): Tools for Assessing the Management of Severe Maternal Morbidity. PLoS ONE 7(8): 2012 18. Say L, Souza JP, Pattinson RC. Maternal near miss--towards a standard tool for monitoring quality of maternal health care. Best Pract Res Clin Obstet Gynaecol 2009; 23: 287–296. 19. Nelissen E, Mduma E, Broerse J, Ersdal H, Evjen-Olsen B, et al. Applicability of the WHO Maternal Near Miss Criteria in a Low-Resource Setting. PLoS ONE 8(4): 2013. 20. Neligan PJ, Laff ey JG. Clinical review: Special populations - critical illness and pregnancy. Critical Care 2011, 15:227. 21. Knight M, Callaghan W, Berg C. et al.Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy and Childbirth 2009, 9:55 22. Vest A, Cho L. Hipertension in pregnancy. Cardiol Clin 30 .2012;407–423 23. Aurangzeb I, George L, Raoof S. Amniotic fluid embolism. Crit Care Clin 2004, 20:643-650 24. Nanda S, Nelson-Piercy C, Mackillop L. Cardiac disease in pregnancy. Clinical Medicine 2012, Vol 12, No 6: 553–560 25. Centre for Maternal and Child Enquiries (CMACE): Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006-08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011, 118 (Suppl. 1):1-203. 26. Saenz, R. Lozano, N. Instituto Nacional de Salud Proceso R02. Vigilancia y Control en Salud Pública. Documento Marco Sala Situacional. 2009. 27. Bergonzoli, G. Sala Situacional: instrumento para la vigilancia de salud pública. Primera edición. Marzo 2006. 28. Lindquist A, Knight M, Kurinczuk JJ. Variation in severe maternal morbidity according to socioeconomic position: a UK national case–control study. BMJ Open 2013;3:e002742. 29. Mackenbach JP, Stirbu I, Roskam AJ, Schaap MM, Menvielle G, et al. Socioeconomic inequalities in health in 22 European countries. N Engl J Med (2008) 358: 2468–2481. 30. Kayem G, Kurinczuk J, Lewis G, Golightly S, Brocklehurst P, et al. Risk Factors for Progression from Severe Maternal Morbidity to Death: A National Cohort Study. PLoS ONE (2011) 6(12): e29077 31. Morse ML, Fonseca SC, Gottgtroy CL, Waldmann CS, Gueller E: Severe maternal morbidity and near misses in a regional reference hospital. Rev Bras Epidemiol 2011, 14:310–322 32. Baskett TF, Sternadel J. Maternal intensive care and near-miss mortality in obstetrics. Br J Obstet Gynaecol. 1998;105(9):981-984. 33. Orsini J, Butala A, Diaz L, Muzylo E. et al. Clinical Profile of Obstetric Patients Admitted to the Medical-Surgical Intensive Care Unit (MSICU) of an Inner-City Hospital in New York.J Clin Med Res . 2012;4(5):314-317 34. Than NG, Romero R, Meiri H, Erez O, Xu Y, Tarquini F, et al. PP13, maternal ABO blood groups and the risk assessment of pregnancy complications. PLoS One 2011;6:e21564. 35. Wiggins KL, Smith NL, Glazer NL, Rosendaal FR, Heckbert SR, Psaty BM, et al. ABO genotype and risk of thrombotic events and hemorrhagic stroke. J Thromb Haemost 2009;7:263–9. 36. Lee B, Zhang Z, Wikman A, Lindqvist P, Reilly M. ABO and RhD blood groups and gestational hypertensive disorders: a population-based cohort study. BJOG 2012;119:1232–1237. 37. G.A. Dekker, P.Y. Robillard Pre-eclampsia: is the immune maladaptation hypothesis still standing? An epidemiological update J. Reprod. Immunol, 76 (1-2) (2007), pp. 8-16 38. G.A. Dekker, P.Y. Robillard Immune maladaptation in the aetiology of preeclampsia; an updated epidemiological perspective , Preeclampsia. Aetiology and clinical practice, Cambridge University Press, Cambridge (2007), pp. 276-294 39. Pacheco et al.: Factors associated with severe maternal morbidity and near miss in the São Francisco Valley, Brazil: a retrospective, cohort study. BMC Pregnancy and Childbirth 2014 14:91. TEME |
| Palavras-Chave | #618.25 #Embarazo #Mujeres embarazadas #Atención prenatal #Maternal near miss, risk factors |
| Tipo |
info:eu-repo/semantics/bachelorThesis |
